Clinical Trials

US-based Nexalin Technology has unveiled a third-generation HALO Clarity 15 milliamp (mA) neurostimulation device. The company plans to conduct decentralised clinical trials for the HALO...

Neuralace Medical has received US Food and Drug Administration (FDA) clearance of Axon Therapy to treat chronic Painful Diabetic Neuropathy (PDN). Related: 3Spine completes enrolment...

Tennessee-based medical device firm 3Spine has announced that it has completed the enrolment in a clinical trial set to pave the way for regulatory...

Biosensor company Zedzen has partnered with the Imperial College Healthcare NHS Trust to conduct a clinical study investigating its non-invasive sensing device. The DiCET clinical...

US-based Cardionomic has completed the patient enrolment in its two pilot studies, STIM-ADHF and STOP-ADHF, evaluating the cardiac pulmonary nerve stimulation (CPNS) system in...

MULGRAVE, Australia and PALO ALTO, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- GYDER ® Surgical, a MedTech company specialising in intuitive, non-invasive orthopaedic navigation...

Vivasure Medical has treated the first patient in a clinical study investigating its large-hole synthetic closure system in patients undergoing percutaneous cardiovascular procedures. The successful...

Advanced total artificial heart designer and developer Carmat has announced the first Aeson heart implantation in a patient suffering from a cardiac tumour. The patient...

RevBio has secured approval from the US Food and Drug Administration to start a first-in-human clinical trial for its regenerative bone adhesive for cranial...